Breaking News, Collaborations & Alliances

NorthStar Medical Radioisotopes Enter Strategic Supply Pact

NorthStar to provide Alpha-9 with its non-carrier added Actinium-225 (Ac-225) for use in development and clinical programs.

NorthStar Medical Radioisotopes, LLC, a company involved in the development, production and commercialization of radiopharmaceuticals, and Alpha-9 Oncology Inc., a clinical stage biotechnology company developing highly targeted radiopharmaceuticals to treat a range of cancers, entered into a long-term strategic supply agreement for NorthStar to provide Alpha-9 with its non-carrier added Actinium-225 (Ac-225) for use in its development and clinical programs. “NorthStar, using its advance...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters